Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 159 entries
Sorted by: Best Match Show Resources per page
Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy.

Vaccines

Anichini G, Gandolfo C, Fabrizi S, Miceli GB, Terrosi C, Gori Savellini G, Prathyumnan S, Orsi D, Battista G, Cusi MG.
PMID: 32028593
Vaccines (Basel). 2020 Feb 03;8(1). doi: 10.3390/vaccines8010066.

An increase in measles cases worldwide, with outbreaks, has been registered in the last few years, despite the availability of a safe and highly efficacious vaccine. In addition to an inadequate vaccination coverage, even in high-income European countries studies...

Cite
Anichini G, Gandolfo C, Fabrizi S, et al. Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines (Basel). 2020;8(1)doi: 10.3390/vaccines8010066.
Anichini, G., Gandolfo, C., Fabrizi, S., Miceli, G. B., Terrosi, C., Gori Savellini, G., Prathyumnan, S., Orsi, D., Battista, G., & Cusi, M. G. (2020). Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines, 8(1), . https://doi.org/10.3390/vaccines8010066
Anichini, Gabriele, et al. "Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy." Vaccines vol. 8,1 (2020). doi: https://doi.org/10.3390/vaccines8010066
Anichini G, Gandolfo C, Fabrizi S, Miceli GB, Terrosi C, Gori Savellini G, Prathyumnan S, Orsi D, Battista G, Cusi MG. Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines (Basel). 2020 Feb 03;8(1). doi: 10.3390/vaccines8010066. PMID: 32028593; PMCID: PMC7158681.
Copy Download .nbib Format: NLM
Prevalence of Maternal Measles Antibody and Its Associated Factors among Infants in Coastal Karnataka, India.

Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine

Sathiyanarayanan S, Kumar P, Rao CR, Kumar A, Kamath A, Kamath V.
PMID: 32029990
Indian J Community Med. 2020 Jan-Mar;45(1):83-88. doi: 10.4103/ijcm.IJCM_259_19.

BACKGROUND: The current recommendation in India to commence first dose of measles immunization is at 9 months of age. The effectiveness of measles vaccination is greatly impacted by the level of maternal measles antibody (MMA) during infancy.OBJECTIVES: To find...

Cite
Sathiyanarayanan S, Kumar P, Rao CR, et al. Prevalence of Maternal Measles Antibody and Its Associated Factors among Infants in Coastal Karnataka, India. Indian J Community Med. 2020;45(1):83-88doi: 10.4103/ijcm.IJCM_259_19.
Sathiyanarayanan, S., Kumar, P., Rao, C. R., Kumar, A., Kamath, A., & Kamath, V. (2020). Prevalence of Maternal Measles Antibody and Its Associated Factors among Infants in Coastal Karnataka, India. Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine, 45(1), 83-88. https://doi.org/10.4103/ijcm.IJCM_259_19
Sathiyanarayanan, S, et al. "Prevalence of Maternal Measles Antibody and Its Associated Factors among Infants in Coastal Karnataka, India." Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine vol. 45,1 (2020): 83-88. doi: https://doi.org/10.4103/ijcm.IJCM_259_19
Sathiyanarayanan S, Kumar P, Rao CR, Kumar A, Kamath A, Kamath V. Prevalence of Maternal Measles Antibody and Its Associated Factors among Infants in Coastal Karnataka, India. Indian J Community Med. 2020 Jan-Mar;45(1):83-88. doi: 10.4103/ijcm.IJCM_259_19. PMID: 32029990; PMCID: PMC6985954.
Copy Download .nbib Format: NLM
Preventing congenital rubella infection in the European Region of WHO: 2010 target.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Spika JS, Hanon FX, Wassilak S, Pebody RG, Emiroglu N.
PMID: 29183454
Euro Surveill. 2004 Apr;9(4):3-4. doi: 10.2807/esm.09.04.00455-en.

The World Health Organisation (WHO) Regional Office for Europe has recently published a strategic plan and surveillance guidelines for measles and congenital rubella infection. The strategy prioritises measles control activities but encourages the introduction of rubella vaccine when measles...

Cite
Spika JS, Hanon FX, Wassilak S, et al. Preventing congenital rubella infection in the European Region of WHO: 2010 target. Euro Surveill. 2004;9(4):3-4doi: 10.2807/esm.09.04.00455-en.
Spika, J. S., Hanon, F. X., Wassilak, S., Pebody, R. G., & Emiroglu, N. (2004). Preventing congenital rubella infection in the European Region of WHO: 2010 target. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 9(4), 3-4. https://doi.org/10.2807/esm.09.04.00455-en
Spika, J S, et al. "Preventing congenital rubella infection in the European Region of WHO: 2010 target." Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin vol. 9,4 (2004): 3-4. doi: https://doi.org/10.2807/esm.09.04.00455-en
Spika JS, Hanon FX, Wassilak S, Pebody RG, Emiroglu N. Preventing congenital rubella infection in the European Region of WHO: 2010 target. Euro Surveill. 2004 Apr;9(4):3-4. doi: 10.2807/esm.09.04.00455-en. PMID: 29183454.
Copy Download .nbib Format: NLM
Two decades of regional trends in vaccination completion and coverage among children aged 12-23 months: an analysis of the Uganda Demographic Health Survey data from 1995 to 2016.

BMC health services research

Okello G, Izudi J, Ampeire I, Nghania F, Dochez C, Hens N.
PMID: 34996445
BMC Health Serv Res. 2022 Jan 07;22(1):40. doi: 10.1186/s12913-021-07443-8.

BACKGROUND: Childhood vaccination is an important public health intervention but there is limited information on coverage, trends, and determinants of vaccination completion in Uganda at the regional level. We examined trends in regional vaccination coverage and established the determinants...

Cite
Okello G, Izudi J, Ampeire I, et al. Two decades of regional trends in vaccination completion and coverage among children aged 12-23 months: an analysis of the Uganda Demographic Health Survey data from 1995 to 2016. BMC Health Serv Res. 2022;22(1):40doi: 10.1186/s12913-021-07443-8.
Okello, G., Izudi, J., Ampeire, I., Nghania, F., Dochez, C., & Hens, N. (2022). Two decades of regional trends in vaccination completion and coverage among children aged 12-23 months: an analysis of the Uganda Demographic Health Survey data from 1995 to 2016. BMC health services research, 22(1), 40. https://doi.org/10.1186/s12913-021-07443-8
Okello, Gerald, et al. "Two decades of regional trends in vaccination completion and coverage among children aged 12-23 months: an analysis of the Uganda Demographic Health Survey data from 1995 to 2016." BMC health services research vol. 22,1 (2022): 40. doi: https://doi.org/10.1186/s12913-021-07443-8
Okello G, Izudi J, Ampeire I, Nghania F, Dochez C, Hens N. Two decades of regional trends in vaccination completion and coverage among children aged 12-23 months: an analysis of the Uganda Demographic Health Survey data from 1995 to 2016. BMC Health Serv Res. 2022 Jan 07;22(1):40. doi: 10.1186/s12913-021-07443-8. PMID: 34996445.
Copy Download .nbib Format: NLM
Concordance of vaccination status and associated factors with incomplete vaccination: a household survey in the health district of Segou, Mali, 2019.

The Pan African medical journal

Sangaré S, Sangho O, Doumbia L, Marker H, Sarro YDS, Dolo H, Telly N, Zakour IB, Ndiaye HM, Sanogo M, Sangho F, Diarra NH, Sangho A, Traoré FB, Diallo B, Coulibaly CA, Ongoiba S, Diakité L, Doumbia S.
PMID: 34887977
Pan Afr Med J. 2021 Oct 14;40:102. doi: 10.11604/pamj.2021.40.102.29976. eCollection 2021.

INTRODUCTION: the region of Segou recorded 36.8% of children were incompletely vaccinated in 2018. In 2019, the district of Segou was one of the districts with the lowest vaccination coverage in the region, with 85.1% coverage for the three...

Cite
Sangaré S, Sangho O, Doumbia L, et al. Concordance of vaccination status and associated factors with incomplete vaccination: a household survey in the health district of Segou, Mali, 2019. Pan Afr Med J. 2021;40:102doi: 10.11604/pamj.2021.40.102.29976.
Sangaré, S., Sangho, O., Doumbia, L., Marker, H., Sarro, Y. D. S., Dolo, H., Telly, N., Zakour, I. B., Ndiaye, H. M., Sanogo, M., Sangho, F., Diarra, N. H., Sangho, A., Traoré, F. B., Diallo, B., Coulibaly, C. A., Ongoiba, S., Diakité, L., & Doumbia, S. (2021). Concordance of vaccination status and associated factors with incomplete vaccination: a household survey in the health district of Segou, Mali, 2019. The Pan African medical journal, 40102. https://doi.org/10.11604/pamj.2021.40.102.29976
Sangaré, Sidiki, et al. "Concordance of vaccination status and associated factors with incomplete vaccination: a household survey in the health district of Segou, Mali, 2019." The Pan African medical journal vol. 40 (2021): 102. doi: https://doi.org/10.11604/pamj.2021.40.102.29976
Sangaré S, Sangho O, Doumbia L, Marker H, Sarro YDS, Dolo H, Telly N, Zakour IB, Ndiaye HM, Sanogo M, Sangho F, Diarra NH, Sangho A, Traoré FB, Diallo B, Coulibaly CA, Ongoiba S, Diakité L, Doumbia S. Concordance of vaccination status and associated factors with incomplete vaccination: a household survey in the health district of Segou, Mali, 2019. Pan Afr Med J. 2021 Oct 14;40:102. doi: 10.11604/pamj.2021.40.102.29976. eCollection 2021. PMID: 34887977; PMCID: PMC8627150.
Copy Download .nbib Format: NLM
The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial.

Japanese journal of infectious diseases

Platt H, Tochihara S, Oda Y, Ueda K.
PMID: 33518626
Jpn J Infect Dis. 2021 Sep 22;74(5):429-436. doi: 10.7883/yoken.JJID.2020.876. Epub 2021 Jan 29.

The domestic combined measles-mumps-rubella (MMR) vaccine was withdrawn in Japan in 1993 following an outbreak of aseptic meningitis attributed to the mumps component of the cocktail. KM-248 is an MMR vaccine (M-M-R

Cite
Platt H, Tochihara S, Oda Y, et al. The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial. Jpn J Infect Dis. 2021;74(5):429-436doi: 10.7883/yoken.JJID.2020.876.
Platt, H., Tochihara, S., Oda, Y., & Ueda, K. (2021). The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial. Japanese journal of infectious diseases, 74(5), 429-436. https://doi.org/10.7883/yoken.JJID.2020.876
Platt, Heather, et al. "The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial." Japanese journal of infectious diseases vol. 74,5 (2021): 429-436. doi: https://doi.org/10.7883/yoken.JJID.2020.876
Platt H, Tochihara S, Oda Y, Ueda K. The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial. Jpn J Infect Dis. 2021 Sep 22;74(5):429-436. doi: 10.7883/yoken.JJID.2020.876. Epub 2021 Jan 29. PMID: 33518626.
Copy Download .nbib Format: NLM
Status epilepticus outcomes among vaccinated and unvaccinated children: A population-based study.

Epilepsy & behavior : E&B

Deng L, Macartney K, Gill D, Fathima P, Wood N, Gidding H.
PMID: 34920348
Epilepsy Behav. 2021 Dec 14;126:108482. doi: 10.1016/j.yebeh.2021.108482. Epub 2021 Dec 14.

AIM: To determine the proportion of first status epilepticus (SE) cases that are vaccine-proximate (VP-) and compare clinical outcomes to non-vaccine-proximate (NVP-) cases.METHODS: Birth records for 1,440,807 Australian children born in 1998-2012, were probabilistically linked to hospitalizations, deaths, and...

Cite
Deng L, Macartney K, Gill D, et al. Status epilepticus outcomes among vaccinated and unvaccinated children: A population-based study. Epilepsy Behav. 2021;126:108482doi: 10.1016/j.yebeh.2021.108482.
Deng, L., Macartney, K., Gill, D., Fathima, P., Wood, N., & Gidding, H. (2021). Status epilepticus outcomes among vaccinated and unvaccinated children: A population-based study. Epilepsy & behavior : E&B, 126108482. https://doi.org/10.1016/j.yebeh.2021.108482
Deng, Lucy, et al. "Status epilepticus outcomes among vaccinated and unvaccinated children: A population-based study." Epilepsy & behavior : E&B vol. 126 (2021): 108482. doi: https://doi.org/10.1016/j.yebeh.2021.108482
Deng L, Macartney K, Gill D, Fathima P, Wood N, Gidding H. Status epilepticus outcomes among vaccinated and unvaccinated children: A population-based study. Epilepsy Behav. 2021 Dec 14;126:108482. doi: 10.1016/j.yebeh.2021.108482. Epub 2021 Dec 14. PMID: 34920348.
Copy Download .nbib Format: NLM
[Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis].

Virologie (Montrouge, France)

Maillard P.
PMID: 34479445
Virologie (Montrouge). 2005 Feb 01;9(1):69-70. doi: 10.1684/vir.2020.1291.

No abstract available.

Cite
Maillard P. Virus de la rougeole recombinant comme stratégie vaccinale contre le virus West-Nile. [Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis]. Virologie (Montrouge). 2005;9(1):69-70doi: 10.1684/vir.2020.1291.
Maillard, P. (2005). Virus de la rougeole recombinant comme stratégie vaccinale contre le virus West-Nile. [Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis]. Virologie (Montrouge, France), 9(1), 69-70. https://doi.org/10.1684/vir.2020.1291
Maillard, Patrick. "Virus de la rougeole recombinant comme stratégie vaccinale contre le virus West-Nile." [Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis]. Virologie (Montrouge, France) vol. 9,1 (2005): 69-70. doi: https://doi.org/10.1684/vir.2020.1291
Maillard P. Virus de la rougeole recombinant comme stratégie vaccinale contre le virus West-Nile. [Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis]. Virologie (Montrouge). 2005 Feb 01;9(1):69-70. doi: 10.1684/vir.2020.1291. French. PMID: 34479445.
Copy Download .nbib Format: NLM
Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018.

Tropical medicine and health

Thar AMC, Wai KT, Harries AD, Show KL, Mon LL, Lin HH.
PMID: 32047360
Trop Med Health. 2020 Feb 07;48:4. doi: 10.1186/s41182-020-0191-4. eCollection 2020.

BACKGROUND: There is a global resurgence of measles, consequent upon worldwide stagnating measles vaccination coverage. The study aim was to document trends and characteristics of reported cases of measles, measles-related deaths, and measles vaccination coverage (MCV1-first dose of measles-containing...

Cite
Thar AMC, Wai KT, Harries AD, et al. Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018. Trop Med Health. 2020;48:4doi: 10.1186/s41182-020-0191-4.
Thar, A. M. C., Wai, K. T., Harries, A. D., Show, K. L., Mon, L. L., & Lin, H. H. (2020). Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018. Tropical medicine and health, 484. https://doi.org/10.1186/s41182-020-0191-4
Thar, Aye Mya Chan, et al. "Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018." Tropical medicine and health vol. 48 (2020): 4. doi: https://doi.org/10.1186/s41182-020-0191-4
Thar AMC, Wai KT, Harries AD, Show KL, Mon LL, Lin HH. Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018. Trop Med Health. 2020 Feb 07;48:4. doi: 10.1186/s41182-020-0191-4. eCollection 2020. PMID: 32047360; PMCID: PMC7006084.
Copy Download .nbib Format: NLM
The Impact of War in Yemen on Immunization Coverage of Children Under One Year of Age: Descriptive Study.

JMIR public health and surveillance

Torbosh A, Al Amad MA, Al Serouri A, Khader Y.
PMID: 31647465
JMIR Public Health Surveill. 2019 Oct 23;5(4):e14461. doi: 10.2196/14461.

BACKGROUND: After 2 years of war that crippled the capacity of the Yemeni National Health System and left only 45% of health facilities functioning, Yemen faced increasing vaccine-preventable disease (VPD) outbreaks and may be at high risk of polio...

Cite
Torbosh A, Al Amad MA, Al Serouri A, et al. The Impact of War in Yemen on Immunization Coverage of Children Under One Year of Age: Descriptive Study. JMIR Public Health Surveill. 2019;5(4):e14461doi: 10.2196/14461.
Torbosh, A., Al Amad, M. A., Al Serouri, A., & Khader, Y. (2019). The Impact of War in Yemen on Immunization Coverage of Children Under One Year of Age: Descriptive Study. JMIR public health and surveillance, 5(4), e14461. https://doi.org/10.2196/14461
Torbosh, Amr, et al. "The Impact of War in Yemen on Immunization Coverage of Children Under One Year of Age: Descriptive Study." JMIR public health and surveillance vol. 5,4 (2019): e14461. doi: https://doi.org/10.2196/14461
Torbosh A, Al Amad MA, Al Serouri A, Khader Y. The Impact of War in Yemen on Immunization Coverage of Children Under One Year of Age: Descriptive Study. JMIR Public Health Surveill. 2019 Oct 23;5(4):e14461. doi: 10.2196/14461. PMID: 31647465; PMCID: PMC6913770.
Copy Download .nbib Format: NLM
Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake.

PloS one

Brownstone S, Connor A, Stein D.
PMID: 32663234
PLoS One. 2020 Jul 14;15(7):e0236542. doi: 10.1371/journal.pone.0236542. eCollection 2020.

No abstract available.

Cite
Brownstone S, Connor A, Stein D. Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake. PLoS One. 2020;15(7):e0236542doi: 10.1371/journal.pone.0236542.
Brownstone, S., Connor, A., Stein, D. (2020). Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake. PloS one, 15(7), e0236542. https://doi.org/10.1371/journal.pone.0236542
Brownstone, Steven, et al. "Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake." PloS one vol. 15,7 (2020): e0236542. doi: https://doi.org/10.1371/journal.pone.0236542
Brownstone S, Connor A, Stein D. Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake. PLoS One. 2020 Jul 14;15(7):e0236542. doi: 10.1371/journal.pone.0236542. eCollection 2020. PMID: 32663234; PMCID: PMC7360039.
Copy Download .nbib Format: NLM
Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018.

Vaccine

Jean Baptiste AE, Masresha B, Wagai J, Luce R, Oteri J, Dieng B, Bawa S, Ikeonu OC, Chukwuji M, Braka F, Sanders EAM, Hahné S, Hak E.
PMID: 33875267
Vaccine. 2021 Nov 17;39:C89-C95. doi: 10.1016/j.vaccine.2021.03.095. Epub 2021 Apr 17.

INTRODUCTION: All WHO regions have set measles elimination objective for 2020. To address the specific needs of achieving measles elimination, Nigeria is using a strategy focusing on improving vaccination coverage with the first routine dose of (monovalent) measles (MCV1)...

Cite
Jean Baptiste AE, Masresha B, Wagai J, et al. Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018. Vaccine. 2021;39:C89-C95doi: 10.1016/j.vaccine.2021.03.095.
Jean Baptiste, A. E., Masresha, B., Wagai, J., Luce, R., Oteri, J., Dieng, B., Bawa, S., Ikeonu, O. C., Chukwuji, M., Braka, F., Sanders, E. A. M., Hahné, S., & Hak, E. (2021). Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018. Vaccine, 39C89-C95. https://doi.org/10.1016/j.vaccine.2021.03.095
Jean Baptiste, Anne Eudes, et al. "Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018." Vaccine vol. 39 (2021): C89-C95. doi: https://doi.org/10.1016/j.vaccine.2021.03.095
Jean Baptiste AE, Masresha B, Wagai J, Luce R, Oteri J, Dieng B, Bawa S, Ikeonu OC, Chukwuji M, Braka F, Sanders EAM, Hahné S, Hak E. Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018. Vaccine. 2021 Nov 17;39:C89-C95. doi: 10.1016/j.vaccine.2021.03.095. Epub 2021 Apr 17. PMID: 33875267.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 159 entries